Thoughts on IPI. Thoughts on suicide. Where is California workers’ comp headed? What’s next for FDA? Vitale: Just pay the players.
Can digital health apps save the NHS millions? Allow more opioids? Why are subway construction costs so high in the U.S? R is the future. Are ACA plans getting too expensive: …in almost all of Nebraska, a 60-year-old with a $50,000 income would pay between 30 percent and 50 percent of that income in premiums…
FHIR. Measuring trust in physicians. Neighborhood effects on BMI. Dentists earn monopoly rents? Does having kids make you happy? “Sell it all.”
Medication adherence and physician quality. Drug price iceberg. Trust, but verify. Fewer hospitals offering substance use disorder services. Build your own Medicare for all.
Regulation and quality: home health edition. NICE + CADTH = consultants? The start of price transparency? Gottlieb: Use of RWD, machine learning in clinical trials Experiencing patient experience.
Women in economics. Opioids and hepatitis C. Fax machines never die. War on drug-related deaths. Expanding tech in clinical trials.
Spouse vs. patient preferences for nursing homes. Food swamps. Medicaid and moral hazard. Medicare access to anti-opioid medications. The price ain’t right. Brexit and access to pharmaceuticals. Cure for cancer?
Government shutdown slows drug approvals. Does emailing your doctor save or cost money? Digital health and direct-to-consumer marketing. A smart watch for epilepsy. Genetic instrumental variables (GIV). The groin crusher.
Super gonorrhoea The cost of H1N1 influenza outbreaks. Do wellness programs save money? Government shutdown’s impact on healthcare “the marginal return to the tough-on-crime stance may be close to zero”
Drug innovation and disease burden. Five lessons not learned from previous government shutdowns. “parents of daughters…become almost twice as risk-averse as parents of sons” Immigration and health care wait time in the US. Drug “kingpin captures cause large…increases to the homicide rate”